Patent · US Active

Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals

US8507710B2 · kind B2 · utility

0Cited by

8References

6Claims

0Family size

Assignee

Aeterna Zentaris, Inc. · DE

Inventors

Jurgen Engel · Alzenau, DE
Eckhard Gunther · Offenbach, DE
Herbert Sindermann · Rodgau, DE

Key dates

Filing date	Mar 31, 2010
Grant date	Aug 13, 2013
Priority date	—
Expiry date	Oct 8, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to pharmaceutical compositions comprising alkylphosphocholines and antimetabolite antitumor substances. The pharmaceutical compositions of the invention are useful for the treatment of benign and malignant oncoses in humans and animals. Preferred alkylphosphocholines are described by the Formula II.One such preferred alkylphosphocholine is perifosine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.